These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9583005)

  • 1. Decreased interleukin-2 production in Korean schizophrenic patients.
    Kim YK; Lee MS; Suh KY
    Biol Psychiatry; 1998 May; 43(9):701-4. PubMed ID: 9583005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased serum levels of interleukin-2 and interleukin-6 in Indian Bengalee schizophrenic patients.
    Singh B; Bera NK; Nayak CR; Chaudhuri TK
    Cytokine; 2009 Jul; 47(1):1-5. PubMed ID: 19502081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated interleukin-2, interleukin-6 and interleukin-8 serum levels in neuroleptic-free schizophrenia: association with psychopathology.
    Zhang XY; Zhou DF; Zhang PY; Wu GY; Cao LY; Shen YC
    Schizophr Res; 2002 Oct; 57(2-3):247-58. PubMed ID: 12223256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in interleukin-1 beta and soluble interleukin-2 receptor levels in CSF and serum of schizophrenic patients.
    Barak V; Barak Y; Levine J; Nisman B; Roisman I
    J Basic Clin Physiol Pharmacol; 1995; 6(1):61-9. PubMed ID: 8562579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum interleukin 1 alpha and interleukin 2 levels in patients with schizophrenia.
    Ebrinç S; Top C; Oncül O; Başoğlu C; Cavuşlu S; Cetin M
    J Int Med Res; 2002; 30(3):314-7. PubMed ID: 12166349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma levels of interleukin-1 beta and interleukin-6 in schizophrenia, other psychoses, and affective disorders.
    Katila H; Appelberg B; Hurme M; Rimón R
    Schizophr Res; 1994 Apr; 12(1):29-34. PubMed ID: 8018583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered IL-2, IL-6 and IL-8 serum levels in schizophrenia patients with tardive dyskinesia.
    An HM; Tan YL; Shi J; Wang ZR; Soars JC; Wu JQ; Yang FD; Huang XF; Zhang XY
    Schizophr Res; 2015 Mar; 162(1-3):261-8. PubMed ID: 25600548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum IL-1beta, sIL-2R, IL-6, IL-8 and TNF-alpha in schizophrenic patients, relation with symptomatology and responsiveness to risperidone treatment.
    Erbağci AB; Herken H; Köylüoglu O; Yilmaz N; Tarakçioglu M
    Mediators Inflamm; 2001 Jun; 10(3):109-15. PubMed ID: 11545247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitogen-stimulated interleukin-2 production in never-medicated, first-episode schizophrenic patients. The influence of age at onset and negative symptoms.
    Ganguli R; Brar JS; Chengappa KR; DeLeo M; Yang ZW; Shurin G; Rabin BS
    Arch Gen Psychiatry; 1995 Aug; 52(8):668-72. PubMed ID: 7632120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum interleukin-6 in schizophrenic patients.
    Shintani F; Kanba S; Maruo N; Nakaki T; Nibuya M; Suzuki E; Kinoshita N; Yagi G
    Life Sci; 1991; 49(9):661-4. PubMed ID: 1865759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased Interleukin-17 and decreased BAFF serum levels in drug-free acute schizophrenia.
    El Kissi Y; Samoud S; Mtiraoui A; Letaief L; Hannachi N; Ayachi M; Ali BBH; Boukadida J
    Psychiatry Res; 2015 Jan; 225(1-2):58-63. PubMed ID: 25453636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum TNF-α, IL-10 and IL-2 in schizophrenic patients before and after treatment with risperidone and clozapine.
    Ajami A; Abedian F; Hamzeh Hosseini S; Akbarian E; Alizadeh-Navaei R; Taghipour M
    Iran J Immunol; 2014 Sep; 11(3):200-9. PubMed ID: 25265997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine production in drug-free and neuroleptic-treated schizophrenic patients.
    Bessler H; Levental Z; Karp L; Modai I; Djaldetti M; Weizman A
    Biol Psychiatry; 1995 Sep; 38(5):297-302. PubMed ID: 7495923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased interleukin-2 serum levels were associated with psychopathological symptoms and cognitive deficits in treatment-resistant schizophrenia.
    Tan Y; Li Y; Tan S; Wang Z; Yang FD; Cao B; Zunta-Soares GB; Soares JC; Zhang XY
    Schizophr Res; 2015 Dec; 169(1-3):16-21. PubMed ID: 26549630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cortisol and cytokines in chronic and treatment-resistant patients with schizophrenia: association with psychopathology and response to antipsychotics.
    Zhang XY; Zhou DF; Cao LY; Wu GY; Shen YC
    Neuropsychopharmacology; 2005 Aug; 30(8):1532-8. PubMed ID: 15886721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum interleukin-6 concentration in schizophrenia: elevation associated with duration of illness.
    Ganguli R; Yang Z; Shurin G; Chengappa KN; Brar JS; Gubbi AV; Rabin BS
    Psychiatry Res; 1994 Jan; 51(1):1-10. PubMed ID: 7910974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased production of interleukin-2 (IL-2), IL-2 secreting cells and CD4+ cells in medication-free patients with schizophrenia.
    Zhang XY; Zhou DF; Cao LY; Zhang PY; Wu GY
    J Psychiatr Res; 2002; 36(5):331-6. PubMed ID: 12127601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study of adiponectin, IL-1β, IL-6 and TNF-α in first episode drug naїve schizophrenia].
    Song XQ; Chen XM; Zhang W; Li X; Hei GR; Li YH; Hao YH; Lü LX
    Zhonghua Yi Xue Za Zhi; 2013 Nov; 93(41):3256-60. PubMed ID: 24401617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum interleukin-18 levels are elevated in schizophrenia.
    Tanaka KF; Shintani F; Fujii Y; Yagi G; Asai M
    Psychiatry Res; 2000 Sep; 96(1):75-80. PubMed ID: 10980328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased interleukin-1 and interleukin-3 like activity in schizophrenic patients.
    Sirota P; Schild K; Elizur A; Djaldetti M; Fishman P
    Prog Neuropsychopharmacol Biol Psychiatry; 1995 Jan; 19(1):75-83. PubMed ID: 7708934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.